Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK/Akt/HIF-1α-induced twist expression.

Chen PC, Tai HC, Lin TH, Wang SW, Lin CY, Chao CC, Yu HJ, Tsai YC, Lai YW, Lin CW, Tang CH.

Oncotarget. 2017 Aug 10;8(43):74506-74518. doi: 10.18632/oncotarget.20171. eCollection 2017 Sep 26.

2.

Identification of Nidogen 1 as a lung metastasis protein through secretome analysis.

Alečković M, Wei Y, LeRoy G, Sidoli S, Liu DD, Garcia BA, Kang Y.

Genes Dev. 2017 Jul 15;31(14):1439-1455. doi: 10.1101/gad.301937.117. Epub 2017 Aug 21.

3.

Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.

Evola FR, Costarella L, Pavone V, Caff G, Cannavò L, Sessa A, Avondo S, Sessa G.

Front Pharmacol. 2017 Apr 7;8:150. doi: 10.3389/fphar.2017.00150. eCollection 2017. Review.

4.

Periostin is required for matricellular localization of CCN3 in periodontal ligament of mice.

Takayama I, Tanabe H, Nishiyama T, Ito H, Amizuka N, Li M, Katsube KI, Kii I, Kudo A.

J Cell Commun Signal. 2017 Mar;11(1):5-13. doi: 10.1007/s12079-016-0371-5. Epub 2016 Dec 24.

5.

CCN family of proteins: critical modulators of the tumor cell microenvironment.

Yeger H, Perbal B.

J Cell Commun Signal. 2016 Sep;10(3):229-240. Epub 2016 Aug 12.

6.

Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment.

Chen PC, Cheng HC, Wang J, Wang SW, Tai HC, Lin CW, Tang CH.

Oncotarget. 2014 Mar 30;5(6):1595-608.

7.

CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.

Sciandra M, Marino MT, Manara MC, Guerzoni C, Grano M, Oranger A, Lucarelli E, Lollini PL, Dozza B, Pratelli L, Renzo MF, Colombo MP, Picci P, Scotlandi K.

J Bone Miner Res. 2014;29(5):1295-309. doi: 10.1002/jbmr.2141.

8.

Protein kinase C epsilon and genetic networks in osteosarcoma metastasis.

Goudarzi A, Gokgoz N, Gill M, Pinnaduwage D, Merico D, Wunder JS, Andrulis IL.

Cancers (Basel). 2013 Apr 8;5(2):372-403. doi: 10.3390/cancers5020372.

9.

CCN proteins: A centralized communication network.

Perbal B.

J Cell Commun Signal. 2013 Aug;7(3):169-77. doi: 10.1007/s12079-013-0193-7. Epub 2013 Feb 19.

10.

Flaws in the peer-reviewing process : a critical look at a recent paper studying the role of CCN3 in renal cell carcinoma.

Perbal B.

J Cell Commun Signal. 2012 Aug;6(3):181-4. doi: 10.1007/s12079-012-0174-2. Epub 2012 Aug 3.

11.

CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis.

Ouellet V, Siegel PM.

J Cell Commun Signal. 2012 Jun;6(2):73-85. doi: 10.1007/s12079-012-0161-7. Epub 2012 Mar 18.

12.

Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/Dox.

Yao L, Zhang Y, Chen K, Hu X, Xu LX.

PLoS One. 2011;6(9):e24684. doi: 10.1371/journal.pone.0024684. Epub 2011 Sep 8.

13.

CCN3 suppresses mitogenic signalling and reinstates growth control mechanisms in Chronic Myeloid Leukaemia.

McCallum L, Lu W, Price S, Lazar N, Perbal B, Irvine AE.

J Cell Commun Signal. 2012 Mar;6(1):27-35. doi: 10.1007/s12079-011-0142-2. Epub 2011 Jul 20.

14.

The molecular pathogenesis of osteosarcoma: a review.

Broadhead ML, Clark JC, Myers DE, Dass CR, Choong PF.

Sarcoma. 2011;2011:959248. doi: 10.1155/2011/959248. Epub 2011 Apr 13.

15.

CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone.

Ouellet V, Tiedemann K, Mourskaia A, Fong JE, Tran-Thanh D, Amir E, Clemons M, Perbal B, Komarova SV, Siegel PM.

Am J Pathol. 2011 May;178(5):2377-88. doi: 10.1016/j.ajpath.2011.01.033.

16.

CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.

Rocchi A, Manara MC, Sciandra M, Zambelli D, Nardi F, Nicoletti G, Garofalo C, Meschini S, Astolfi A, Colombo MP, Lessnick SL, Picci P, Scotlandi K.

J Clin Invest. 2010 Mar;120(3):668-80. doi: 10.1172/JCI36667. Epub 2010 Feb 8.

17.

CCN3: a key growth regulator in Chronic Myeloid Leukaemia.

McCallum L, Lu W, Price S, Lazar N, Perbal B, Irvine AE.

J Cell Commun Signal. 2009 Jun;3(2):115-24. doi: 10.1007/s12079-009-0058-2. Epub 2009 Jul 22.

18.

Regulatory role of CCN3 in melanoma cell interaction with the extracellular matrix.

Vallacchi V, Rodolfo M.

Cell Adh Migr. 2009 Jan-Mar;3(1):7-10. Epub 2009 Jan 21.

19.

The CCN family of proteins: structure-function relationships.

Holbourn KP, Acharya KR, Perbal B.

Trends Biochem Sci. 2008 Oct;33(10):461-73. doi: 10.1016/j.tibs.2008.07.006. Epub 2008 Sep 11. Review.

20.

CCN3: Doctor Jekyll and Mister Hyde.

Perbal B.

J Cell Commun Signal. 2008 Jun;2(1-2):3-7. doi: 10.1007/s12079-008-0028-0. Epub 2008 Sep 12.

Supplemental Content

Support Center